Reprints
PubMed
CAVEAT LECTOR
Dieter Kabelitz & Ottmar Janssen
Department of Immunology, Paul-Ehrlich-Institute, Langen, Germany
Received 1/24/97; Accepted 1/31/97 On-line 2/15/97
1. J. F. R. Kerr, A. H. Wyllie & A. R. Currie: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257 (1972)
2. J F R Kerr & B V Harmon: Definition and Incidence of Apoptosis: An Historical Perspective. In: Apoptosis: The molecular basis of cell death. Eds: Tomei L D, Cope F O, Cold Spring Harbor Laboratory Press (1991)
3. J. Savill, I. Dransfied, N. Hogg & C. Haslett. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343, 170-173 (1990)
4. A. H. Wyllie: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 184, 555-56 (1980)
5. G Kroemer, C Martínez-A: Apoptosis in immunology. In: Curr Top Microbiol Immunol, vol. 200, Springer-Verlag, Heidelberg Berlin New York (1995)
6. K. Schulze-Osthoff, H. Walczak, W. Dröge & P. H. Krammer: Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127, 15-20 (1994)
7. G. M. Cohen, X.-M. Sun, R. T. Snowden, D. Dinsdale & D. N. Skiletter: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286, 331-4 (1992)
8. M. E. Peter, J. Dhein, A. Ehret, S. Hellbardt, H. Walczak, G. Moldenhauer & P. H. Krammer: APO-1(CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int Immunol 7, 1873-7 (1995)
9. C. L. Tucek-Szabo, S. Andrjelic, E. Lacy, K. B. Elkon & J. Nikolic-Zugic: Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. J Immunol 156, 192-200 (1996)
10. B. Mollereau, M. Deckert, O. Déas, F. Rieux-Laucat, F. Hirsch, A. Bernard, A. Fischer, D. H. Lynch, B. Charpentier, F. Le Deist & A. Senik: CD2-induced apoptosis in activated human peripheral T cells. A Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol 156, 3184-90 (1996)
11. P. D. Katsikis, M. E. García-Ojeda, E. S. Wunderlich, C. A. Smith, H. Yagita, K. Okumura, N. Kayagaki, M. Alderson, L. A. Herzenberg & L. A. Herzenberg: Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int Immunol 8, 1311-7 (1996)
12. D. Kabelitz, T. Pohl & K. Pechhold: Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14, 338-9 (1993)
13. G. T. Williams, C. A. Smith, E. Spooncer, T. M. Dexter & D. R. Taylor: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343, 76-9 (1990)
14. N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto & S. Nagata: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-43 (1991)
15. N. Itoh, S. Nagata: A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268, 10932-7 (1993)
16. T. Suda, T. Takahashi, P. Golstein & S. Nagata: Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 75, 1169-78 (1993)
17. S. Nagata & P. Golstein: The Fas death factor. Science 267, 1449-56 (1995)
18. S. R. Wiley, K. Schooley, P. J. Smolak, W. S. Din, C.-P. Huang, J. K. Nicholi, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith & R. G. Goodwin: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-82 (1995)
19. E. Rouvier, M.-F. Luciani & P. Golstein: Fas involvement in Ca2+-independent T cell-mediated cytotoxicity. J Exp Med 177, 195-200 (1993)
20. S.-T. Ju, H. Ciu, D. J. Panka, R Ettinger & A. Marshak-Rothstein: Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ T cells. Proc Natl Acad Sci USA 91, 4185-4189 (1994)
21. S. Yonehara, A. Ishii & M. Yonehara: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor for tumor necrosis factor. J Exp Med 169, 1747-1756 (1989)
22. C. Klas, K. M. Debatin, R. Jonker & P. H. Krammer: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5, 625-630 (1993)
23. T. Stalder, S. Hahn & P. Erb: Fas antigen is the major target molecule for CD4+ T cell mediated cytotoxicity. J Immunol 152, 1127-1133 (1994)
24. M.G. Cifone, R De Maria, P. Roncaioli, M. R. Rippo, M. Azuma, L. L. Lanier, A. Santoni & R. Testi: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 177, 1547-1552 (1993)
25. L. M. Obeid, C. M. Linardic, L. A. Karolak & Y. A. Hannun: Programmed cell death induced by ceramide. Science 259, 1769-71 (1993)
26. E. Gulbins, R. Bissonette, A. Mahboubi, S. Martin, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, C. Byrd, F. Lang, R. Kolesnick, A. Altman & D. Green: Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 2, 341-351 (1995)
27. E. Gulbins, B. Brenner, K. Schlottmann, J. Welsch, H. Heinle, U. Koppenhoefer, O. Linderkamp, K. M. Coggeshall & F. Lang: Fas-induced programmed cell death is mediated by a Ras-regulated O2- synthesis. Immunology 89, 205-12 (1996)
28. H.-D. Um, J. M. Orenstein & S. M. Wahl: Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 156, 3469-77 (1996)
29. A. M. Chinnaiyan, K. O'Rourke, M. Tewari & V. M. Dixit: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512 (1995)
30. B. Z. Stanger, P. Leder, T.-H. Lee, E. Kim & B. Seed: RIP: a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell death. Cell 81, 513-523 (1995)
31. T. Sato, s. Irie, S. Kitada & J. C. Reed. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268, 411-415 (1995)
32. Q. Tian, J. L. Taupin, S. Elledge, M. Robertson & P. Anderson: Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med 182, 865-874 (1995)
33. C. M. Eischen, C. J. Dick & P. J. Leibson: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153, 1947-1954 (1994)
34. O. Janssen, B. Lengl-Janßen, H.-H. Oberg, M. J. Robertson & D. Kabelitz: Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation. Immunol Letters, 49, 63-69 (1996)
35. F. C. Kischkel, S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer & M. E. Peter: Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14, 5579-5588 (1995)
36. M. Muzio, A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter & V. M. Dixit: FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85, 817-27 (1996)
37. M. P. Boldin, T. M. Goncharov, Y. V. Goltsev & D. Wallach: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-15 (1996)
38. D. W. Nicholson, A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y A. Lazebnik, N. A. Munday, S. M. Raju, M. E. Smulson, T.-T. Yamin, V. L. Yu & D. K. Miller: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43 (1995)
39. T. Fernandes-Alnemri, M. G. Litwack & E. S. Alnemri: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1ß-converting enzyme. J Biol Chem 269, 30761-4 (1994)
40. L. Casciola-Rosen, D. W. Nicholson, T. Chong, K. R. Rowan, N. A. Thornberry, D. K. Miller & A. Rosen: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 182, 1957-64 (1996)
41. A. Sarin, M.-L. Wu & P. A. Henkart: Different interleukin-1ß converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med 184, 2445-50 (1996)
42. J. Dhein, H. Walczak, C. Bäumler, K.-M. Debatin & P. H. Krammer: Autocrine T cell suicide mediated by Apo-1/(Fas/CD95). Nature 373, 438-441 (1995)
43. T. Brunner, R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware & D. R. Green: Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444 (1995)
44. S.-T. Ju, D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger & A. Marshak-Rothstein: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448 (1995)
45. S. M. Mariani, B. Matiba, C. Bäumler, P. H. Krammer: Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25, 2302-7 (1995)
46. L. Zheng, G., Fisher, R. E. Miller, J. Peschon, D. H. Lynch & M. J. Lenardo: Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-51 (1995)
47. H. K. Sytwu, R. S. Liblau, H. O. McDevitt: The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5: 17-30 (1996)
48. J. G. Gribben, G. J. Freeman, V. A. Boussiotis, P. Rennert, C. L. Jellis, E. Greenfield, M. Barber, V. A. Restivo, Jr., X. Ke, G. S. Gray & L. M. Nadler: CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92: 811-15 (1995)
49. P. Kisielow & H. von Boehmer: Development and selection of T cells: Facts and puzzles. Adv Immunol 58: 87-209 (1995)
50. J. Drappa, N. Brot & K. B. Elkon: The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci USA 90, 10340-44 (1993)
51. G. G. Singer & A. K. Abbas: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-71 (1994)
52. C. L. Sidman, J. D. Marshall, H. von Boehmer: Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol 22, 499-504 (1992)
53. J. E. Castro, J. A. Listman, B. A. Jacobson, Y. Wang, P. A. Lopez, S. Ju, P. W. Finn & D. L. Perkins. Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5, 617-27 (1996)
54. G. H. Fisher, M. J. Lenardo & J. C. Zúñiga-Pflücker: Synergy between T cell receptor and Fas (CD95/APO-1) signaling in mouse thymocyte death. Cell Immunol 169, 99-106 (1996)
55. C. A. Smith, G. T. Williams, R. Kingston, E. J. Jenkinson & J. J. T. Owen: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337: 181-4 (1989)
56. Y. Shi, R. P. Bissonnette, N. Parfrey, M. Szalay,, R. T. Kubo & D. R. Green: in vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol 146, 3340-6 (1991)
57. D. J. McConkey, P. Hartzell, J. F. Amador-Pérez, S. Orrenius & M. Jondal: Calcium-dependent killing of immature thymocytes by stimulation via the CD3/ T cell receptor complex. J Immunol 143: 1801-6 (1989)
58. E. J. Jenkinson, R. Kingston, C. A. Smith, G. T. Williams & J. J. T. Owen: Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol 19, 2175-7 (1989)
59. H. Acha-Orbea, A. N. Shakhov, L. Scarpellino, E. Kolb, V. Müller, A. Vessaz-Shaw, R. Fuchs, K. Bölchlinger, P. Rollini, J. Billotte, M. Sarafidou & H. R. MacDonald: Clonal deletion of Vß14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350, 207-11 (1991)
60. R. L. Wange & L. E. Samelson: Complex complexes: Signaling at the TCR. Immunity 5, 197-205 (1996)
61. S. C. Meuer, J. C. Hodgdon, R. E. Hussey, J. P. Protentis, S. F. Schlossman & E. L. Reinherz: Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med 158, 988-993 (1983)
62. S. C. Meuer, R. E. Hussey, D. A. Cantrell, J. C. Hodgdon, S. F. Schlossman, K. A. Smith & Ellis L. Reinherz: Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci USA 81, 1509-13 (1984)
63. T. Tadakuma, H. Kizaki, C. Odaka, R. Kubota, Y. Ishimura, H. Yagita & K. Okumura: CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur J Immunol 20: 779-84 (1990)
64. M. Mercep, J. A. Bluestone, P. D. Noguchi & J. D. Ashwell: Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J Immunol 140, 324-35 (1988)
65. S. Takahashi, H. T. Maecker & R. Levy: DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line. Eur J Immunol 19, 1911-19 (1989)
66. D. S. Ucker, J. D. Ashwell & G. Nickas: Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol 143, 3461-69 (1989)
67. C. Odaka, H. Kizaki & T. Tadakuma. T cell receptor-mediated DNA fragmentation and cell death in T cell hybridomas. J Immunol 144, 2096-2101 (1990)
68. S. Vukmanovic & R. Zamoyska: Anti-CD3-induced cell death in T cell hybridomas: mitochondrial failure and DNA fragmentation are distinct event. Eur J Immunol 21: 419-24 (1991)
69. Y. Shi, M. G. Szalay, L. Paskar, M. Boyer, B. Singh & D. Green: Activation-induced cell death in T cell hybridomas is due to apoptosis. Morpholog aspects and DNA fragmentation J Immunol 144, 3326-33 (1990)
70. G. J. Nau, R. L. Moldwin, D. W. Lancki, D.-K. Kim & F. W. Fitch: Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody. J Immunol 139, 114-22 (1987)
71. S. Webb & J. Sprent: Downregulation of T cell responses by antibodies to the T cell receptor. J Exp Med 165, 584-9 (1987)
72. G. J. Nau, D.-K. Kim & F. W. Fitch: Agents that mimic antigen receptor signaling inhibit proliferation of cloned murine T lymphocytes induced by IL-2. J Immunol 141, 3557-63 (1988)
73. J. B. Breitmeyer, S. O. Oppenheim, J. F. Daley, H. B. Levine & S. F. Schlossman: Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex. J Immunol 138, 726-31 (1987)
74. J. J. Russell, C. L. White, D. Y. Loh & P. Meleedy-Rey: Receptor-stimulated death pathway is opened by antigen in mature T cell. Proc Natl Acad Sci USA 88, 2151-55 (1991)
75. A. Bensussan, G. Leca, N. Corvaïa & L. Boumsell. Selective induction of autocytotoxic activity through the CD3 molecule. Eur J Immunol 20, 2615-19 (1990)
76. O. Janssen, S. Wesselborg & D. Kabelitz: Immunosuppression by OKT3:-induction of programmed cell death (apoptosis) as a possible mechanism of action. Transplantation 53, 233-4 (1992)
77. G. Kroemer: The pharmacology of T cell apoptosis. Adv Immunol 58, 211-96 (1995)
78. S. Wesselborg, O. Janssen & D. Kabelitz: Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 150: 4338-45 (1993)
79. L. G. Radvanyi, G. B. Mills & R. G. Miller: Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 150: 5704-15 (1993)
80. M. Salmon, D. Pilling, N. J. Borthwick, N. Viner, G. Janossy, P. A. Bacon & A. N. Akbar: The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24: 892-9 (1994)
81. O. Janssen, S. Wesselborg, B. Heckl-Österreicher, K. Pechhold, A. Bender, S. Schondelmaier, G. Moldenhauer & D. Kabelitz: T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gammadelta+ T cells. J Immunol 146, 35-9 (1991)
82. B. Adkins, K. Chun, K. Hamilton & M. Nassiri: Naive murine neonatal T cells undergo apoptosis in response to primary stimulation. J Immunol 157, 1343-9 (1996)
83. M. J. Lenardo: Interleukin-2 programs mouse alphaß T lymphocytes for apoptosis. Nature 353, 858-861 (1991)
84. R. Wang, A. M. Rogers, B. J. Rush & J. H. Russell: Induction of sensitivity to activation-induced death in primary CD4+ cells: a role for interleukin-2 in the negative regulation of responses by mature CD4+ T cells. Eur J Immunol 26, 2263-70 (1996)
85. S. A. Boehme & M. J. Lenardo: Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 23, 1552-1560 (1993)
86. M. K. Newell, L. J. Haughn, C. R. Maroun & M. H. Julius: Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347, 286-9 (1990)
87. N. K. Banda, J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R.-P. Sekaly & T. H. Finkel: Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176, 1099-1106 (1992)
88. H. Groux, G. Torpier, D. Monté, Y. Mouton, A. Capron & J.-C. Ameisen: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175: 331-40 (1992)
89. M.-L. Gougeon, L. Montagnier: Apoptosis in AIDS. Science 260, 1269-72 (1993)
90. J. H. Russell, B. J. Rush, S. I. Abrams, R. Wang: Sensitivity of T cells to anti-CD3-stimulated suicide is independent of functional phenotype. Eur J Immunol 22: 1655-8 (1992)
91. B. Combadière, M. Freedman, L. Chen, E. W. Shores, P. Love & M. J. Lenardo: Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis. J Exp Med 183, 2109-17 (1996)
92. P. Marrack & J. Kappler: The staphylococcal enterotoxins and their relatives. Science 248, 705-711 (1990)
93. Y. Kawabe & A. Ochi: Programmed cell death and extrathymic reduction of Vß8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349: 245-8 (1991)
94. J. A. Gonzalo, I. M. de Alborán, J. E. Alés-Martínez, C. Martínez-A. & G. Kroemer: Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway. Eur J Immunol 22: 1007-11 (1992)
95. Y. Kawabe & A. Ochi: Selective anergy of Vß8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J Exp Med 172: 1065-70 (1990)
96. B. L. Rellahan, L. A. Jones, A. M. Kruisbeek, A. M. Fry & L. A. Matis: in vivo induction of anergy in peripheral Vß8+ T cells by staphylococcal enterotoxin B. J Exp Med 172: 1091-1100 (1990)
97. H. R. MacDonald, S. Baschieri & R. K. Lees: Clonal expansion precedes anergy and death of Vß8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur J Immunol 21: 1963-6 (1991)
98. D. E. Scott, W. J. Kisch & A. D. Steinberg: Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol 150, 664-72 (1993)
99. S. Baschieri, R. K. Lees, A. R. Lussow & H. R. MacDonald: Clonal expansion to staphylococcal enterotoxin B in vivo: selective effects on T cell subsets and lymphokines. Eur J Immunol 23: 2661-6 (1993)
100. K. Heeg, S. Bendigs, T. Miethke & H. Wagner: Induction of unresponsiveness to the superantigen staphylococcal enterotoxin B: cyclosporin A resistant split unresponsiveness unfolds in vivo without preceding clonal expansion. Int Immunol 5, 929-37 (1993)
101. M. E. Hamel, E. E. Eynon, H. F. J. Savelkoul, A. van Oudenaren & A. M. Kruisbeek: Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B. Int Immunol 7, 1065-77 (1995)
102. O. Williams, J. A. Gonzalo & C. Martínez-A: Staphylococcal enterotoxin B promotes deletion and functional inactivation of CD4 Vß8-positive cells in the absence of CD8 T cells. Scand J Immunol 38, 254-58 (1993)
103. A. R. Lussow, T. Crompton, O. Karapetian & H. R. MacDonald: Peripheral clonal deletion of superantigen-reactive T cells is enhanced by cortisone. Eur J Immunol 23, 578-81 (1993)
104. E. Z. Tchilian, G. Anderson, N. C. Moore, J. J. T. Owen & E. J. Jenkinson: Involvement of LFA-1/ICAM-2 adhesive interactions and PKC in activation-induced cell death following SEB rechallenge. Immunology 87, 566-72 (1996)
105. D. Kabelitz & S. Wesselborg: Life and death of a superantigen-reactive human CD4+ T cell clone: staphylococcal enterotoxins induce death by apoptosis but simultaneously trigger a proliferative response in the presence of HLA-DR+ antigen-presenting cells. Int Immunol 4, 1381-88 (1992)
106. N. K. Damle, G. Leytze, K. Klussman & J. A. Ledbetter: Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism. Eur J Immunol 23, 1513-22 (1993)
107. R. Baccala, B. A. E. Vandekerckhove, D. Jones, D. H. Kono, M.-G. Roncarolo & A. N. Theofilopoulos: Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model. J Exp Med 177, 1481-5 (1993)
108. G. A. Waanders, A. N. Shakhov, W. Held, O. Karapetian, H. Acha-Orbea & H. R. MacDonald: Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med 177, 1359-66 (1993)
109. H. Wang, R. F. Gill, D. Lichlyter, A. Iglesias, H. Bluethmann & W.-Z. Wei: Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected Vß2 transgenic mice. Eur J Immunol 24, 2950-6 (1994)
110. J. H. Russell, D. E. Manning, D. E. McCulley & P. Meleedy-Rey: Antigen as a positive and negative regulator of proliferation in cytoxic lympohocytes. A model for the differential regulation of proliferation and lytic activity. J Immunol 140, 1796-1801 (1988)
111. G. Suzuki, Y. Kawase, S. Koyasu, I. Yahara, Y. Kobayashi & R. H. Schwartz: Antigen-induced suppression of the proliferative response of T cell clones. J Immunol 140, 1359-65 (1988)
112. S. Brocke, M. Dayan, L. Steinman, J. Rothbard & E. Mozes: Inhibition of T cell proliferation specific for acetylcholine receptor epitopes related to myasthenia gravis with antibody to T cell receptor or with competitive synthetic polymers. Int Immunol 2, 735-742 (1990)
113. D. J. Moss, S. R. Burrows, G. D. Baxter & M. F. Lavin: T cell-T cell killing is induced by specific epitopes: Evidence for an apoptotic mechanism. J Exp Med 173, 681-86 (1991)
114. P. R. Walden & H. N. Eisen: Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci USA 87, 9015-9019 (1990)
115. R. M. Pemberton, D. C. Wraith & B. A. Askonas: Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells. Immunology 70, 223-5 (1990)
116. J. P. Dutz, P. R. Walden & H. N. Eisen: Effects of cognate peptides on cytolytic and proliferative activities of cloned cytotoxic T lymphocytes. Int Immunol 4, 571-80 (1992)
117. A. Suhrbier, S R. Burrows, A. Fernan, M. F. Lavin, G. D. Baxter & D. J. Moss: Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination. J Immunol 150, 2169-78 (1993)
118. J. P. Christensen, C. Röpke & A. R. Thomsen: Virus-induced polyclonal T cell activation is followed by apoptosis: partitioning of CD8+ T cells based on alpha4 integrin expression. Int Immunol 8, 707-15 (1996)
119. D. Kyburz, P. Aichele, D. E. Speiser, H. Hengartner, R. M. Zinkernagel & H. Pircher: T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 23, 1956-62 (1993)
120. D. A. Carlow, S. J. Teh, N. S. C. van Oers, R. G. Miller & H.-S. Teh: Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells. Int Immunol 4, 599-610 (1992)
121. J. Kirberg, L. Bruno & H. von Boehmer: CD4+8- help prevents rapid deletion of CD8+ cells after a transient response to antigen. Eur J Immunol 23, 1963-7 (1993)
122. L. Zhang, D. R. Martin, W.-P. Fung-Leung, H.-S. Teh & R. G. Miller: Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. J Immunol 148, 3740-5 (1992)
123. C. Mamalaki, Y. Tanaka, P. Corbella, P. Chandler, E. Simpson & D. Kioussis: T cell deletion follows chronic antigen specific T cell activation in vivo. Int Immunol 5, 1285-92 (1993)
124. S. R. Sambhara & R. G. Miller: Programmed cell death of T cells signaled by the T cell receptor and the alpha3 domain of class I MHC. Science 252, 1424-7 (1991)
125. T. Pohl, K. Pechhold, H.-H. Oberg, O. M. Wilbert & D. Kabelitz: Antigen-induced death of alloreactive human T-lymphocytes occurs in the absence of low molecular weight DNA fragmentation. Cell Immunol 166, 187-95 (1995)
126. L. Zhang. The fate of adoptively transferred antigen-specific T cells in vivo. Eur J Immunol 26: 2208-14 (1996)
127. N. Zavazava & M. Krönke: Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 2, 1005-10 (1996)
128. D. Kabelitz, H.-H. Oberg, T. Pohl & K. Pechhold: Antigen-induced death of mature T lymphocytes: Analysis by flow cytometry. Immunol Rev 142, 157-74 (1994)
129. N. K. Damle, K. Klussman, G. Leytze, A. Aruffo, P. S. Linsley & J. A. Ledbetter: Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes. J Immunol 151, 2368-79 (1993)
130. F. Bettens, E. Frei, K. Frutig, D. Mauri, W. J. Pichler & T. Wyss-Coray: Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis. Cell Immunol 161, 72-8 (1995)
131. C. M. Pelfrey, L. R. Tranquill, S. A. Boehme, H. F. McFarland & M. J. Lenardo: Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derrived from multiple sclerosis patients and normal individuals. J Immunol 154, 6191-6202 (1995)
132. B. Nag, T. Kendrick, S. Arimilli, S. C. T. Yu & S. Sriram: Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells. Cell Immunol 170, 25-33 (1996)
133. M. A. Alexander-Miller, G. R. Leggatt, A. Sarin & J. A. Berzofsky: Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med 184, 485-92 (1996)
134. J. M. Critchfield, J. C. Zúñiga-Pflücker & M. J. Lenardo: Parameters controlling the programmed death of mature mouse T lymphocytes in high-dose suppression. Cell Immunol 160, 71-8 (1995)
135. R. S. Liblau, C. I. Pearson, K Shokat, R. Tisch, X.-D. Yang & H. O. McDevitt: High-dose soluble antigen: Peripheral T-cell proliferation or apoptosis. Immunol Rev 142, 193-208 (1994)
136. M. R. Alderson, T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell & D. H. Lynch. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181, 71-7 (1995)
137. M. Boshell, J. McLeod, L. Walker, N. Hall, Y. Patel & D. Sansom: Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells. Immunology 87, 586-92 (1996)
138. R. J. Mogil, L. Radvanyi, R. Gonzalez-Quintial, R. Miller, G. Mills, A. N. Theofilopoulos & D. R. Green: Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int Immunol 7, 1451-8 (1995)
139. T. Renno, M. Hahne, J. Tschopp & H. R. MacDonald: Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med 183, 431-7 (1996)
140. S. Nagata & T. Suda: Fas and Fas ligand: lpr and gld mutations. Immunol Today 16, 39-43 (1995)
141. L. Van Parijs, A. Ibraghimov & A. K. Abbas: The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4, 321-328 (1996)
142. J. H. Russell, B. Rush,, C. Weaver & R. Wang: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90, 4409-13 (1993)
143. P. Bossu, G. G. Singer, P. Andres, R. Ettinger, A. Marshak-Rothstein & A. K. Abbas: Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J Immunol 151, 7233-39 (1993)
144. C. L. Tucek-Szabo, S. Andjelic, E. Lacy K. B. Elkon & J. Nikolic-Zugic: Surface T cell Fas receptor/CD95 regulation, in vivo activation and apoptosis. J Immunol 156, 192-200 (1996)
145. S.-J. Teh, J. P. Dutz, B. Motyka & H.-S. Teh: Fas (CD95)-independent regulation of immune responses by antigen-specific CD4-CD8+ T cells. Int Immunol 8, 675-81 (1996)
146. R. E. O'Hehir & J. R. Lamb: Induction of specific clonal anergy in human T lymphocytes by Staphyloccus aureus enterotoxins. Proc Natl Acad Sci USA 87, 8884-8 (1990)
147. D. Falb, T. J. Briner, G. H. Sunshine, C. R. Bourque, M. Luqman, M. L. Gefter & T. Kamradt: Peripheral tolerance in T cell receptor-transgenic mice: Evidence for T cell anergy. Eur J Immunol 26, 130-5 (1996)
148. G. Schönrich, U. Kalinke, F. Momburg, M. Malissen, A.-M. Schmitt-Verhulst, B. Malissen, G. J. Hämmerling & B. Arnold: Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65, 293-304 (1991)
149. S. Webb, C. Morris & J. Sprent: Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 63, 1249-1256 (1990)
150. L. D'Adamio, K. M. Awad & E. L. Reinherz: Thymic and peripheral apoptosis of antigen-specific T cells might cooperate in establishing self tolerance. Eur J Immunol 23, 747-53 (1993)
151. B. Arnold, G. Schönrich & G. J. Hämmerling: Multiple levels of peripheral tolerance. Immunol Today 14, 12-4 (1993)
152. T. T. Pearson, C. R. Darby, A. R. Bushell, L. J. West, P. J. Morris & K. J. Wood: The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 55, 361-7 (1993)
153. J. F. Markmann, J. S. Odorico, H. Bassiri, N. Desai, J. I. Kim & C. F. Barker. Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 55, 871-7 (1993)
154. Y. Nakafusa, J. A. Goss, T. Mohanakumar & M. W. Flye: Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen. Transplantation 55, 877-82 (1993)
155. L. Campos, E. J. Alfrey, A. M. Posselt, J. S. Odorico, C. F. Barker & A. Naji: Prolonged survival of rat orthotopic liver allografts after intrathymic inoculation of donor-strain cells. Transplantation 55, 866-70 (1993)
156. Y. Shi, B. M. Sahai & D. R. Green: Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339, 625-6 (1989)
157. S. Wesselborg, U. Prüfer, M. Wild, B. Schraven, S. C. Meuer & D. Kabelitz: Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 23, 2707-10 (1993)
158. S. A. McCarthy, R. N. Cacchione, M. S. Mainwaring & J. S. Cairns: The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation 54, 543-7 (1992)
159. K. Migita, K. Eguchi, Y. Kawabe, T. Tsukada, A. Mizokami & S. Nagataki: FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest 96, 727-32 (1995)
160. D. Bellgrau, D. Gold, H. Selawry, J. Moore, A. Franzusoff & R. C. Duke: A role for CD95 ligand in preventing graft rejection. Nature 377, 630-2 (1995)
161. H. Yagita, K.-I. Seino, N. Kayagaki & K. Okumura: CD95 ligand in graft rejection. Nature 379, 682 (1996)
162. T. S. Griffith, X. Yu, J. M. Herndon, D. R. Green & T. A. Ferguson: CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5, 7-16 (1996)
163. M. P. Pender, P. A. McCombe, G. Yoong & K. B. Nguyen: Apoptosis of alphaß T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance. J Autoimmunity 5, 401-10 (1992)
164. Z. Tabi, P. A. McCombwe & M. P. Pender: Apoptotic elimination of Vß8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vß8.2+ encephalitogenic T cells. Eur J Immunol 24, 2609-17 (1994)
165. Z. Tabi, P. A. McCombe & M. P. Pender: Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int Immunol 7, 967-73 (1995)
166. M. A. Cremer, A. D. Hernandez, A. S. Townes, J. M. Stuart & A. H. Kang. Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol 131, 2995-3000 (1983)
167. D. L. Kaufman, M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E.E. Sercarz, A. J. Tobin & P. V. Lehmann: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366, 69-72 (1993)
168. J. M. Critchfield, M. K. Racke, J. C. Zúñiga-Pflücker, B. Cannella, C. S. Raine, J. Goverman, M. J. Lenardo. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263, 1139-1143 (1994)
169. Y. Chen, J.-I. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo & H. L. Weiner: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 1277-80 (1995)
170. J. M. Critchfield & M. J. Lenardo: Antigen-induced programmed T cell death as a new approach to immune therapy. Clin Immunol Immunopathol 75, 13-9 (1995)
171. C. B. Thompson: Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-62 (1995)
172. H. Groux, D. Monte, B. Plouvier, A. Capron & J.-C. Ameisen: CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur J Immunol 23, 1623-9 (1993)
173. Y. Liu & C. A. Janeway Jr.: Interferon gamma plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance. J Exp Med 172, 1735-9 (1990)
174. X. Zhang, L. Giangreco, H. E. Broome, C. M. Dargan & S. L. Swain: Control of CD4 effector fate: Transforming growth factor ß1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 182, 699-709 (1995)
175. M. Radrizzani, P. Accornero, A. Amidei, A. Aiello, D. Delia, R. Kurrle & M. P. Colombo: IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 161, 14-21 (1995)
176. L. G. Radvanyi, Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G. B. Mills & R. G. Miller: CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol 156: 1788-98 (1996)
177. J. C. Ameisen, J. Estaquier, T. Idiorek & F. De Bels: Programmed cell death and AIDS pathogenesis: Significance and potential mechanisms. Curr Top Microbiol Immunol 200: 195-211 (1995)
178. M. Hahne, D. Rimoldi, M. Schröter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J.-C. Cerottini & J. Tschopp: Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape. Science 274, 1363-6 (1996)
179. S. Strand, W. J. Hofmann, H. Hug, M. Müller, G. Otto, D. Strand, S. M. Mariani, W. Stremmel, P. H. Krammer & P. R. Galle: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Med 2, 1361-6 (1996)